AngioDynamics (ANGO) Tops Q4 EPS by 11c, provides guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $13.09 +0.08%
EPS Growth %: -200.0%
Financial Fact:
Diluted weighted average shares outstanding: 36.7M
Today's EPS Names:
CRMT, More
EPS Growth %: -200.0%
Financial Fact:
Diluted weighted average shares outstanding: 36.7M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of ($0.05), $0.10 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $70.98 million versus the consensus estimate of $70.9 million.
GUIDANCE:
AngioDynamics sees FY2025 EPS of ($0.38)-($0.42), versus the consensus of ($0.52). AngioDynamics sees FY2025 revenue of $282-288 million, versus the consensus of $292.7 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Morgan Stanley Downgrades Repsol SA (REP:SM) (REPYY) to Equalweight
- Raymond James Upgrades Aecon Group (ARE:CN) (AEGXF) to Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
